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General anaesthesia versus local anaesthesia for carotid 
surgery (GALA): a multicentre, randomised controlled trial
GALA Trial Collaborative Group*
Summary
Background The eﬀ ect of carotid endarterectomy in lowering the risk of stroke ipsilateral to severe atherosclerotic 
carotid-artery stenosis is oﬀ set by complications during or soon after surgery. We compared surgery under general 
anaesthesia with that under local anaesthesia because prediction and avoidance of perioperative strokes might be 
easier under local anaesthesia than under general anaesthesia.
Methods We undertook a parallel group, multicentre, randomised controlled trial of 3526 patients with symptomatic 
or asymptomatic carotid stenosis from 95 centres in 24 countries. Participants were randomly assigned to surgery 
under general (n=1753) or local (n=1773) anaesthesia between June, 1999 and October, 2007. The primary outcome 
was the proportion of patients with stroke (including retinal infarction), myocardial infarction, or death between 
randomisation and 30 days after surgery. Analysis was by intention to treat. The trial is registered with Current 
Control Trials number ISRCTN00525237.
Findings A primary outcome occurred in 84 (4·8%) patients assigned to surgery under general anaesthesia and 
80 (4·5%) of those assigned to surgery under local anaesthesia; three events per 1000 treated were prevented with 
local anaesthesia (95% CI –11 to 17; risk ratio [RR] 0·94 [95% CI 0·70 to 1·27]). The two groups did not signiﬁ cantly 
diﬀ er for quality of life, length of hospital stay, or the primary outcome in the prespeciﬁ ed subgroups of age, 
contralateral carotid occlusion, and baseline surgical risk.
Interpretation We have not shown a deﬁ nite diﬀ erence in outcomes between general and local anaesthesia for carotid 
surgery. The anaesthetist and surgeon, in consultation with the patient, should decide which anaesthetic technique to 
use on an individual basis.
Funding The Health Foundation (UK) and European Society of Vascular Surgery.
Introduction
Patients with severe atherosclerotic stenosis at the 
internal carotid-artery origin have a high risk of 
ipsilateral ischaemic stroke. On the basis of previous 
randomised trials,1 carotid endarterectomy is often 
advised, particularly after an ipsilateral transient 
ischaemic attack or non-disabling ischaemic stroke.2 
There is less beneﬁ t for asymptomatic carotid stenosis.3 
Several complications may take place during or soon 
after carotid endarterectomy, including stroke in 
5–7% of cases.4 Operative practices under local (or 
regional) anaesthesia may be safer than under general 
anaesthesia, partly because awake testing of brain 
function under local anaesthesia during carotid 
clamping alerts the surgeon to the need for a shunt 
more reliably than the various indirect techniques used 
under general anaesthesia. Consequently, fewer shunts 
are used. Although shunts should protect the brain 
from stroke that results from low cerebral-blood ﬂ ow 
during carotid clamping, they can damage the arterial 
wall causing embolism to the brain.
Some randomised trials of carotid endarterectomy,5 
and spinal and epidural anaesthesia for other types of 
surgery,6 have suggested more beneﬁ ts of local than of 
general anaesthesia. However, sample sizes were often 
small in these studies, and some analyses combined 
diﬀ erent types of patients and procedures. Also, some 
studies were confounded by the use of regional 
anaesthesia as an adjunct to general anaesthesia. We 
have therefore undertaken a large randomised trial of 
general versus local anaesthesia for carotid 
endarterectomy.
Methods
Participants
We enrolled 3526 patients from 95 centres in 24 countries. 
Patients with symptomatic or asymptomatic internal 
carotid stenosis for whom open surgery with either local 
or general anaesthesia was advised were eligible. The 
planned sample size was 5000 patients, on the basis of a 
predicted one-third reduction in risk of a primary 
outcome under local compared with general anaesthesia 
(from 7·5% to 5%); this is a more-conservative treatment 
eﬀ ect than suggested by the Cochrane meta-analysis.5
Exclusion criteria included a simultaneous bilateral 
carotid endarterectomy; carotid endarterectomy 
combined with another operative procedure such as 
coronary-artery bypass surgery; or if patients had 
previously taken part in the trial. The study was approved 
by the Northern and Yorkshire Multicentre Research 
Ethics Committee. All patients gave written informed 
consent.
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Study design
This was a two-arm, parallel group, multicentre 
randomised controlled trial of general anaesthesia versus 
local anaesthesia for carotid surgery (GALA). We published 
complete information of the study protocol elsewhere.7
Each consultant surgeon in the trial centres had to have 
done at least 15 carotid endarterectomy procedures per 
year with either general or local anaesthesia. The 
proportion of trainees—both surgical and anaesthetic—
was balanced as much as possible between the two groups. 
Shunts were to be used in patients who underwent surgery 
with local anaesthesia when awake testing indicated a 
need. Otherwise, we allowed centres to provide general or 
local anaesthesia and surgery according to routine practice, 
and we obtained relevant information for each technique.
For every patient, the local collaborator obtained 
baseline data, which were sent to the trial oﬃ  ce in 
Edinburgh by fax, telephone, or web interface. The oﬃ  ce 
randomised patients to surgery under either general or 
local anaesthesia, stratiﬁ ed by centre and with balanced 
blocks of variable size, ensuring that allocation was 
completely concealed before the decision to randomise a 
patient and after baseline data were received.
We could not blind patients or the surgical team to the 
randomised treatment allocation. However, the indepen-
dent stroke physician or neurologist who saw patients 
1 month after surgery was unaware of the type of 
anaesthesia that the patient had received, although this 
blinding could be broken by the patient or by looking at 
hospital notes. The independent stroke physician or 
neurologist examined the following outcomes: stroke 
(including retinal infarction), myocardial infarction, 
death (and cause), transient ischaemic attack, and other 
complications after surgery. Stroke severity was assessed 
by the modiﬁ ed Rankin scale 6 months after onset by 
post to the patient’s family doctor (or other appropriate 
physician).
For all possible reported primary outcomes, the trial 
oﬃ  ce requested information from hospital notes, death 
certiﬁ cates, or family-doctor records where appropriate. 
Enquiry was made to ensure any reported transient 
ischaemic attack was not a minor stroke, with the usual 
24-h cut-oﬀ  between stroke and transient ischaemic 
attack, without accounting for any hypodensity on brain 
imaging. Myocardial infarction and other coronary events 
were deﬁ ned from clinical history, electrocardiograph, 
and cardiac enzymes. A neurologist (CPW), unaware of 
treatment allocation, then prepared a summary for every 
patient that, depending on the outcome, was audited by 
an independent neurologist (PMR) or cardiologist (APB), 
who were also unaware of treatment allocation.
Data were analysed by the trial statistician (SCL) and 
reviewed annually in strict conﬁ dence by the 
Data Monitoring Committee. Everyone else involved in 
the study was unaware of the treatment allocation until 
the database was locked. The trial was not stopped early; 
indeed, we continued randomisation for 1 year after the 
end of the planned recruitment period. In this way, we 
had less follow-up information on secondary outcomes at 
1 year after surgery in patients randomised during the 
last year of the trial (417 under general anaesthesia and 
428 under local anaesthesia), but a larger sample size for 
the 30-day primary outcome.
Outcome measures
The primary outcome was the proportion of patients with 
stroke (including retinal infarction), myocardial infarc-
tion, or death between randomisation and 30 days after 
anaesthesia (or 30 days after randomisation for the few 
patients for whom surgery was scheduled but not done). 
We examined various secondary outcomes: survival free 
of stroke, myocardial infarction, or death up to 1 year 
after anaesthesia; length of stay in recovery, high-
dependency units, intensive-therapy units, and overall in 
hospital; and, in patients in UK, health-related quality of 
life at about 30 days after anaesthesia with the short 
form (SF)-36 and EuroQoL.
Outcome data were obtained by the surgical or 
anaesthetic team at hospital discharge, 7 days after 
anaesthesia, or death, whichever was ﬁ rst; at 1 month from 
a face-to-face consultation with an independent stroke 
physician or neurologist; and at 1 year from a telephone, 
postal questionnaire, or face-to-face consultation.
Statistical analysis
From randomisation, all patients were accounted for in 
the analysis, whether or not they had received the 
allocated treatment intervention, or even surgery at all. 
We made every eﬀ ort to obtain all outcome data for every 
patient. We excluded patients from analyses if they had 
3526 patients consented and randomised
Allocation
Follow-up
Analysis
1753 allocated to general anaesthesia 
1628 received allocated intervention 
123 did not receive allocated intervention 
2 unknown whether received
allocation: no post-surgery form 
31 no anaesthesia given 
92 cross-overs—other anaesthesia used 
21 incomplete follow-up
1 no follow-up at all
1 no post-surgery form
19 no physician follow-up at one month:
ﬁve of these had patient follow-up at
1 year
1752 analysed: primary outcome
Reasons for exclusions:
No follow-up received for one patient
1771 analysed: primary outcome
Reasons for exclusions:
No follow-up received for two patients
21 incomplete follow-up
2 no follow-up at all
0 no post-surgery form
19 no physician follow-up at one month:
one of these had patient follow-up at
1 year
1773 allocated to local anaesthesia 
1655 received allocated intervention 
116 did not receive allocated intervention 
2 unknown whether received
allocation: no post-surgery form 
41 no anaesthesia given 
75 cross-overs—other anaesthesia used 
Figure 1: Trial proﬁ le
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missing data relevant to a particular analysis, as indicated 
in the results. We calculated the unadjusted relative and 
absolute diﬀ erences in the proportion of patients with a 
primary outcome overall, and in three prespeciﬁ ed 
subgroups: contralateral versus non-contralateral carotid 
occlusion, because predicting and avoiding a perioperative 
low-ﬂ ow ischaemic stroke by appropriate shunting in the 
former group can be particularly important; more or less 
than 75 years old—a cut-oﬀ  deﬁ ned early in the trial 
using the age distribution of patients alone, and not by 
referring to the outcome data; and low versus high 
baseline risk of surgical stroke or death with a previously 
published but non-validated model.8 Post-hoc subgroups 
were baseline risk of surgical stroke or death using a new 
model (Bond R, unpublished), trainee versus experienced 
surgeons and anaesthetists, symptomatic versus 
asymptomatic stenosis, and country (UK versus others). 
We analysed these subgroups with logistic regression, 
with p values calculated from the change in log likelihood 
on entering the interaction between the subgroup eﬀ ect 
and treatment eﬀ ect into the model. We did the analyses 
in SAS version 9.1.3, Revman 5.0, and CIA version 2.1.0.9
Role of the funding source
The funding source had no role in the study design, 
data collection, data analysis, data interpretation, or 
writing of the report. One senior member of the 
European Society for Vascular Surgery was part of the 
steering committee throughout the trial. All authors 
participated in the design and conduct of the GALA trial, 
and in writing and editing the manuscript. They have 
all seen the ﬁ nal version. The corresponding author 
had full access to all the data in the study and had ﬁ nal 
General 
anaesthesia
(N=1753)
Local 
anaesthesia
(N=1773)
Age (years) 70 (8·8) 69 (8·8)
Men 1232 (70%) 1256 (71%)
Hypertension 1334 (76%) 1382 (78%)
Systolic blood pressure (mm Hg)* 145 (20·1) 145 (19·7)
Diastolic blood pressure (mm Hg)* 79 (10·3) 79 (10·8)
Peripheral arterial disease 425 (24%) 446 (25%)
Aortic aneurysm 82 (5%) 70 (4%)
Coronary heart disease 647 (37%) 627 (35%)
Cardiac failure 90 (5%) 93 (5%)
Atrial ﬁ brillation 124 (7%) 111 (6%)
Diabetes 435 (25%) 437 (25%)
Chronic lung disease† 224 (14%) 219 (14%)
Current or ex-smoker 1403 (80%) 1416 (80%)
Baseline surgical risk 1‡
Low (score 0) 878 (50%) 899 (51%)
Medium (score 1) 729 (42%) 721 (41%)
High (score 2 or 3) 146 (8%) 153 (9%)
Baseline surgical risk 2‡
Very low (score 0–4) 332 (19%) 331 (19%)
Low (score 5–9) 695 (40%) 735 (41%)
Medium (score 10–14) 482 (27%) 470 (27%)
High (score 15 or more) 244 (14%) 237 (13%)
ASA grade I or II§ 1147 (65%) 1159 (65%)
Randomised artery to be operated 
on (right)
885 (50%) 863 (49%)
Indication for surgery
Asymptomatic carotid stenosis¶ 685 (39%) 677 (38%)
Carotid stroke only 346 (20%) 346 (20%)
Cerebral TIA (carotid) only 371 (21%) 375 (21%)
Retinal infarct only 32 (2%) 36 (2%)
Amaurosis fugax only 155 (9%) 173 (10%)
More than one of the above 
events
164 (9%) 166 (9%)
(Continues in next column)
General 
anaesthesia
(N=1753)
Local 
anaesthesia
(N=1773)
(Continued from previous column)
Stenosis of randomised artery to 
be operated on (%)
81 (11·1) 81 (11·3) 
Contralateral carotid occlusion 150 (9%) 160 (9%)
Stenosis assessed by||
Ultrasound 1671 (95%) 1666 (94%)
MR angiography 277 (16%) 300 (17%)
CT angiography 224 (13%) 227 (13%)
Catheter angiography 220 (13%) 226 (13%)
Infarct on side of brain relevant to 
operation
363 (35%) 409 (38%)
UK patient 806 (46%) 820 (46%)
Antithrombotic drugs used pre-randomisation**
Aspirin 889 (65%) 913 (67%)
Clopidogrel 105 (8%) 117 (9%)
Dipyridamole 86 (6%) 94 (7%)
Warfarin 21 (2%) 17 (1%)
Data are number (%) or mean (SD), unless otherwise stated. ASA=American Society 
of Anesthesiologists. TIA=transitory ischaemic attack. No scan to image any infarct 
was done in 706 patients under general anaesthesia and 705 under local anaesthesia. 
*Systolic and diastolic blood pressures were unknown for four patients undergoing 
surgery with general anaesthesia and six with local anaesthesia. †Chronic lung disease 
was not assessed in the ﬁ rst 158 patients under general anaesthesia and 
169 under local anaesthesia. ‡Baseline surgical risk 1 of stroke or death: patients score 
one point each for having systolic blood pressure higher than 180 mm Hg, being 
female, and having peripheral arterial disease. Missing blood pressure values were 
assumed to be 180 mm Hg or less. Scores of 2 or 3 were combined into one group 
because of small numbers.8 Baseline surgical risk 2 of stroke or death, patients score: 
age 75 years old or older=2 points, hypertension=3 points, female=4 points, 
diabetes=5 points, symptomatic cerebral event=6 points, contralateral 
occlusion=9 points, redo surgery=10 points, emergency surgery=29 points (Bond R, 
unpublished). §ASA grade I=healthy patient; grade II=mild systemic disease with no 
functional limitation; grade III=severe systemic disease with deﬁ nite functional 
limitation; grade IV=severe systemic disease that is a constant threat to life; grade 
V=moribund patient who is not expected to survive for 24 h with or without surgery. 
¶Symptomatic stenosis is deﬁ ned as a patient who has had symptoms on the 
relevant side at any time in the past. ||Patients could be assessed with more than one 
type of imaging. **This information was recorded after randomisation in 
1358 patients under general anaesthesia and 1371 under local anaesthesia. It was not 
recorded in the ﬁ rst part of the trial.
Table 1: Patient demographic and baseline characteristics
For Revman 5.0 see http://www.
cc-ims.net/RevMan
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responsibility for the decision to submit for pub-
lication.
Results
Recruitment ran from June, 1999 to October, 2007. Database 
was locked on May 1, 2008. We used the ﬁ rst randomisa-
tion for ten patients who were inadvertently randomised 
twice. We removed one patient from the database because 
consent for the trial was not obtained, leaving 3526 for 
analysis (ﬁ gure 1). Table 1 shows the baseline patient 
characteristics. We received post-surgery forms from all 
but two patients in each treatment group (99·9%). 
General 
anaesthesia Local 
anaesthesia
No anaesthesia given
Death before operation 1 1
Stroke before operation 1 1
Carotid artery occluded before operation 8 8
Too ill (condition unrelated to carotid 
disease)
7 6
Carotid stenosis or clinical symptoms too 
mild to warrant surgery
4 11
Patient refusal 9 13
Carotid-stent procedure done instead 1 1
Total 31 41
Anaesthesia used from the outset was opposite to that allocated
Medical decision 41 20
Administrative issues 15 9
Patient’s decision 29 44
Reason unknown 7 2
Total 92 75
Conversions after initiation of anaesthesia
After administration of anaesthesia and before surgery
Patient’s decision ·· 6
Problems with positioning patient on table ·· 3
Patient’s condition deteriorated after 
local-anaesthetic block
·· 8
After start of surgery
Pain at operative site ·· 9
General discomfort, anxiety, 
claustrophobia, and restlessness
·· 25
Physiological instability ·· 5
Protracted or diﬃ  cult surgery ·· 6
Neurological deterioration on 
cross-clamping*
·· 7
Total 0 69
It was known that one patient who was randomly assigned to general anaesthesia 
was anaesthetised, but not which anaesthetic the patient actually received. We 
have assumed that this patient received general anaesthesia, as randomised. The 
information about reasons for non-compliance was generated from free text 
rather than predetermined categories and, in many cases, it was multifactorial. 
We categorised it according to the predominant problem listed. *We do not have 
exact reasons recorded for this, but six patients received a shunt and the seventh 
had a high bifurcation.
Table 2: Reasons for non-compliance with randomisation to anaesthetic 
technique
General 
anaesthesia
Local 
anaesthesia
Post-surgery form received and anaesthesia 
administered
1720 1730
Trainee surgeon* 242 (14%) 210 (12%)
Trainee anaesthetist† 246 (16%) 213 (14%)
Duration of surgery (min)‡ 93 (33·6) 93 (36·0)
Premedication used§ 905 (53%) 877 (51%)
Type of surgery¶
Conventional 1237 (78%) 1145 (72%)
Eversion 317 (20%) 409 (26%)
Exploration only 3 (0·2%) 4 (0·3%)
Other 22 (1%) 14 (1%)
Procedure abandoned 4 (0·2%) 9 (1%)
Shunt used 738 (43%) 248 (14%)
Reasons for using shunt
Neurological deterioration (only 
applicable in patients receiving local 
anaesthesia)
6|| 150
Used routinely 369 35||
Drop in velocity on TCD 45 3||
Unable to use TCD 58 5||
Contralateral carotid occlusion or near 
occlusion
38 5||
Low stump pressure 108 15||
Contralateral carotid stenosis (but not 
occluded or nearly occluded)
4 7||
Recent stroke 5 3||
Unusual or damaged veins or arteries 
in head or neck
2 2||
EEG or evoked potentials changed 8 1||
Blood pressure dropped 4 1||
Falling brain oxygen levels 1 0
Operation converted to vein bypass 1 0
Unknown 89 21
Blood pressure manipulation**
Manipulated up 667 (43%) 267 (17%)
Manipulated down 208 (13%) 433 (28%)
Manipulated up and down 259 (17%) 153 (10%)
Not manipulated 435 (28%) 717 (46%)
Patch used 861 (50%) 728 (42%)
Intraoperative heparin used** 1682 (98%) 1678 (97%)
Data are number (%) or mean (SD). EEG=Electroencephalograph. TCD=Trans-cranial 
doppler. *Experience of surgeon unknown for two patients receiving general 
anaesthesia and ﬁ ve receiving local anaesthesia. †Experience of anaesthetist not 
recorded in ﬁ rst 149 patients receiving general anaesthesia and 161 receiving local 
anaesthesia. ‡Duration of surgery available for 1711 receiving general anaesthesia 
and 1717 receiving local anaesthesia. §Use of premedication unknown for two 
patients receiving general anaesthesia and three receiving local anaesthesia. ¶Type 
of surgery not recorded in ﬁ rst 137 receiving general anaesthesia and 149 receiving 
local anaesthesia. ||Most patients who had these reasons for using shunts received 
the opposite type of anaesthetic. All six patients allocated to general anaethesia who 
received a shunt because of neurological deterioration received the opposite type of 
anaesthetic (local anaesthetic). 50 of 77 (65%) patients receiving local anaesthetic 
with reasons for using shunts other than neurological deterioration received the 
opposite type of anaesthetic (26 patients) or converted (24 patients). 
**Blood-pressure manipulation not recorded in ﬁ rst 151 receiving general 
anaesthesia and 160 receiving local anaesthesia. ††Intra-operative heparin use 
unknown for one patient receiving general anaesthesia.
Table 3: Surgical and anaesthetic procedure
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Slightly more patients who were allocated to local 
anaesthesia did not have surgery, because at examination 
after randomisation it was decided the stenosis or 
symptoms were too mild (table 2). 92 of 1751 (5·3%) pa tients 
assigned to general anaesthesia and 75 of 1771 (4·2%) 
assigned to local anaesthesia underwent surgery but 
received the opposite type of anaesthetic to that allo cated 
at randomisation. Patients who were allocated to general 
anaesthesia were more likely than those allocated to local 
anaesthesia to receive the opposite type of anae sthe-
tic because of a medical decision, whereas patients allo-
cated to local anaesthesia were more likely than those 
allocated to general anaesthesia to receive the opposite 
type of anaesthetic because of patient’s decision. 69 of 
1771 (3·9%) patients assigned to local anaesthesia 
received general anaesthesia after initiation of anaesthe-
sia, 17 before and 52 after the start of surgery.
For patients who received anaesthesia, median time 
from randomisation to surgery was 1 day in both 
treatment groups (IQR 1 to 2 days for local anaesthesia 
and 1 to 3 days for general anaesthesia). The median time 
between the last relevant neurological event and sur-
gery, for symptomatic patients, was 70 days (IQR 27 to 138) 
in the general anaesthesia group, and 72 days 
(IQR 28 to 162) in the local anaesthesia group.
Primary outcome data were available from 1752 of 
1753 patients allocated to general anaesthesia, and 1771 of 
1773 patient allocated to local anaesthesia. Almost all 
patients were followed up by an independent neurologist 
or stroke physician, with only a few assessed just by= the 
surgical or anaesthetic team (equally balanced between 
the treatment groups).
Slightly more patients assigned to local anaesthesia 
than those assigned to general anaesthesia had a 
conventional rather than an eversion endarterectomy 
(table 3). Endarterectomy was repaired with a patch more 
frequently in the general anaesthesia than in the local 
anaesthesia group (50% versus 42%, p<0·001). The mean 
operating (skin-to-skin) time was similar in both 
groups (table 3). The proportion of operations done by 
trainee surgeons and anaesthetists was similar in the two 
groups, as was the use of heparin. Premedication was 
used in about 50% of patients in both groups.
Most patients undergoing general anaesthesia received 
gaseous anaesthetic agents (volatile agents 1244 [84%], 
nitrous oxide 616 [41%]) and muscle relaxants (1481 [91%]), 
and a smaller number received total intravenous 
General 
anaesthesia
Local 
anaesthesia
Post-surgery or physician follow-up 
complete
1752 1771
Stroke* 70 (4·0%) 66 (3·7%)
Fatal 15 11
Non-fatal 55 55
Modiﬁ ed Rankin 6 months after stroke
0–2 41 40
3–5 14 14
Dead 15 12
Ipsilateral to surgery 54 57
Contralateral to surgery 15 7
Vertebrobasilar 1 2
Cerebral infarction 37 41
Retinal infarction 2 3
Cerebral haemorrhage 11 7
Unknown pathology 20 15
Events prevented per 1000 patients 
with local anaesthesia (95% CI)
·· 3 
(–10 to 16)
Myocardial infarction 4 (0·2%) 9 (0·5%)
Fatal 1 3
Non-fatal 3 6
Events prevented per 1000 patients 
with local anaesthesia (95% CI)
·· –3 
(–8 to 2)
Other vascular death 9 5
Stroke (onset before randomisation) 1 0
Coronary heart disease, sudden 2 0
Sudden death without further 
information
1 1
Other coronary heart disease 2 3
Other cardiac (non-coronary) 2 0
Aortic aneurysm rupture 1 0
Pulmonary embolism 0 0
Other 0 1
(Continues in next column)
General 
anaesthesia
Local 
anaesthesia
(Continued from previous column)
Non-vascular death 0 0
Unknown cause of death 1 0
Death (any cause) 26 (1·5%) 19 (1·1%)
Events prevented per 1000 patients 
with local anaesthesia (95% CI)
·· 4
(–3 to 12)
Stroke (including retinal infarction) or 
death
81 (4·6%) 74 (4.2%)
Events prevented per 1000 patients 
with local anaesthesia (95% CI)
·· 4 
(–9 to 18)
Stroke (including retinal infarction), 
myocardial infarction, or death
84 (4·8%) 80 (4·5%)
Events prevented per 1000 patients 
with local anaesthesia (95% CI)
·· 3
(–11 to 17)
Data are number (%) or number (95% CI). Only one event per patient has been 
counted. If a patient had multiple events, the event included in this table is the 
fatal one (if there was one), and the ﬁ rst non-fatal one for all other patients. 
Stroke events are counted in preference to coronary events, and severe events are 
counted over non-severe events. *The number of fatal strokes is diﬀ erent from 
the number of deaths 6 months after the stroke outcome event, because one 
patient died exactly 6 months after the stroke outcome event of an unknown 
cause. There were two events in patients receiving general anaesthesia and two in 
patients receiving local anaesthesia (one stroke and one death in each group) 
after randomisation but before surgery could be done (surgery was cancelled in all 
cases).
Table 4: Primary outcomes between randomisation and 30 days after 
anaesthesia (or after randomisation for patients who were not 
anaesthetised)
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anaesthesia (442 [30%]). Most patients undergoing local 
anaesthesia received a cervical-plexus block (1532 [93%]), 
together with local inﬁ ltration by the anaesthetist 
(1281 [77%]) and supplementary inﬁ ltration by the 
surgeon (1050 [64%]). 791 (48%) had some intra-operative 
sedation and 732 (44%) intra-operative analgesia. More 
patients allocated to general anaesthesia than those 
allocated to local anaesthesia (p<0·001) had their blood 
pressure manipulated up, and more patients allocated to 
local anaesthesia than those allocated to general anaesthesia 
(p<0·001) had their blood pressure mani pulated down or 
not manipulated at all.
Primary outcomes arose in 84 of 1752 (4·8%) patients 
allocated to general anaesthesia and 80 of 
1771 (4·5%) patients allocated to local anaesthesia. Three 
events every 1000 treated were prevented under local 
anaesthesia (risk ratio [RR] 0·94 [95% CI 0·70 to 1·27]; 
table 4). If the patients with missing general anaesthesia 
data were assumed to have had good outcomes, and the 
patients with missing local anaesthesia data poor 
outcomes, then local anaesthesia might prevent two events 
every 1000 treated (95% CI –12 to 16). If the four patients 
who had an event before anaesthesia, together with those 
who never had surgery, underwent exploration only, or 
when surgery was abandoned, and the cross-overs and 
conversions were all removed, then there were 79 primary 
outcomes in 1621 (4·9%) patients under general 
anaesthesia and 64 in 1575 (4·1%) patients under local 
anaesthesia. Eight events every 1000 treated were prevented 
with local anaesthesia (95% CI –6 to +23), similar to what 
we found with the intention-to-treat analysis. 
Death occurred between randomisation and 30 days 
after anaesthesia (or after randomisation for those who 
never had surgery) in slightly more patients under general 
than under local anaesthesia (table 4). Four events every 
1000 treated were prevented (RR 0·72 [95% CI 0·40 to 1·30]). 
Three events every 1000 treated were prevented by local 
anaesthesia (0·93 [0·67 to 1·30]). Slightly more myocardial 
infarctions happened in patients under local anaesthesia 
than under general anaesthesia. None of these diﬀ erences 
was statistically signiﬁ cant.
In four patients allocated to general anaesthesia and 
nine to local anaesthesia (one of whom actually received 
general anaesthesia), anaesthesia was initiated but no 
endarter ectomy was done. The patient who was 
randomised to local anaesthesia but received general 
anaesthesia had heart failure under anaesthesia before 
surgery. Reasons for stopping the procedure in the other 
patients under general anaesthesia were failure to 
intubate, severe bronchospasm after intubation, hypoxia 
with hypertension, and atrial ﬁ brillation. The reasons for 
stopping the procedure in the patients under local 
Prespeciﬁed
Contralateral carotid
occlusion
Age (years)
Baseline surgical risk 1
Post hoc
Baseline surgical risk 2
Trainee surgeon
Trainee anaesthetist
Asymptomatic stenosis
Country
Yes
No
>75
≤75
High
Medium
Low
High
Medium
Low
Very low
Yes
No
Yes
No
Yes
No
UK
Non-UK
15/150
69/1602
26/489
58/1263
6/146
37/728
41/878
17/243
26/482
36/695
5/332
7/242
74/1476
8/246
60/1325
20/685
64/1067
47/806
37/946
8/160
72/1611
21/453
59/1318
7/152
35/720
38/899
14/236
23/470
31/734
12/331
7/210
71/1515
11/213
58/1356
23/676
57/1095
42/820
38/951
(10·0)
(4·3)
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Figure 2: Subgroup analyses on primary outcome of stroke (including retinal infarction), myocardial infarction, or death between randomisation and 30 days 
after anaesthesia (or after randomisation for those patients who did not receive any anaesthetic)
GA=general anaesthesia. LA=local anaesthesia. Big squares represent studies with small 95% CI (ie, with more information); the horizontal lines represent 
the 95% CIs.
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anaesthesia were chest pain after regional block, 
bradycardia after skin incision, severe hypertension, 
vagal reaction followed by severe hypertension, epileptic 
seizures, loss of consciousness (possibly caused by 
injecting anaesthetic into the vertebral artery), respiratory 
insuﬃ  ciency due to presumed phrenic-nerve blockade, 
and signs of cerebral ischaemia during awake testing.
184 (10·5%) patients under general anaesthesia and 
213 (12·0%) under local anaesthesia had cranial-nerve 
injuries. 146 (8·3%) patients under general anaesthesia 
and 150 (8·5%) under local anaesthesia had wound 
haematoma needing re-operation in 45 (2·6%) and 
40 (2·3%) patients, respectively. 35 (2·0%) patients under 
general anaesthesia and 33 (1·9%) under local anaesthesia 
had postoperative chest infections. None of these 
diﬀ erences was statistically signiﬁ cant.
Time to ﬁ rst stroke, myocardial infarction, or death at 
1 year did not diﬀ er signiﬁ cantly between the two groups, 
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Figure 3: Cochrane review for outcome of stroke or death (A) or for outcome of death (B)
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although local anaesthesia gave slightly better results 
(Log-rank test p=0·094). We showed no signiﬁ cant 
diﬀ erences in any of the timing-related outcomes that we 
measured (although the time in the operating theatre 
was not recorded, the operating time was similar; table 3), 
and no substantial diﬀ erence for quality of life at about 
30 days in patients who lived long enough to complete 
the forms.
The eﬀ ect of general and local anaesthesia on the 
primary outcome was not signiﬁ cantly diﬀ erent in the 
three prespeciﬁ ed subgroups (ﬁ gure 2). However, local 
anaesthesia seemed to be more eﬀ ective than general 
anaesthesia for patients with contralateral carotid 
occlusion (ﬁ gure 2). In these patients, 12 strokes and 
one retinal infarct occurred in 150 patients under 
general anaesthesia versus six strokes and one retinal 
infarct in 160 patients under local anaesthesia. These 
strokes were contralateral to the operated artery in 
7 (4·7%) pa tients under general anaesthesia and 
2 (1·2%) under local anaesthesia. However, these 
ﬁ ndings should be viewed with caution.
The original model for baseline surgical risk did not ﬁ t 
our data well, because the proportion of primary 
outcomes did not increase with increasing risk score. 
Consequently, we did a post-hoc analysis with a recently 
developed, but as yet unpublished, measure of baseline 
surgical risk that did not use GALA data in its derivation 
(Bond R, unpublished). This new analysis predicted the 
overall outcome better than did the original analysis, but 
it was still not clear whether local or general anaesthesia 
was better in patients at diﬀ erent risks. No evidence 
existed of an interaction between type of anaesthesia and 
either country (UK versus non-UK, p=0·62), or 
symptomatic versus asymptomatic stenosis (p=0·40). 
The higher surgical risk in the UK than in other countries 
might have been the result of surgeons in non-UK 
centres being much more likely to operate on asymp-
tomatic than symptomatic carotid stenosis (58% vs 16%).
There was a suggestion that trainee surgeons and 
anaesthetists had better results with general anaesthesia 
than with local anaesthesia, but this was not statistic ally 
signiﬁ cant (p=0·7 for surgeons and p=0·3 for 
anaesthetists).
Discussion
The hypothesis that local anaesthesia is better than 
general anaesthesia for carotid endarterectomy is based 
on the idea that it is associated with more appropriate 
and less frequent shunt use, fewer cardiorespira-
tory complications, and preserved cerebrovascular 
autoregulation.10
However, in this study, although general anaesthesia 
was associated with a slightly higher risk than local 
anaesthesia of perioperative stroke, myocardial infarction, 
or death, this diﬀ erence was not statistically signiﬁ cant. 
Patients with contralateral-carotid occlusion might be an 
exception; their risk of stroke seemed higher during 
surgery under general anaesthesia than under local 
anaesthesia, although this was not statistically 
signiﬁ cant.
Nonetheless, local anaesthesia was associated with an 
absolute excess of up to 1% more events, or up to 
2% fewer events, than general anaesthesia. However, 
even when our results are added to those of the 
randomised trials in the Cochrane review, there is still no 
clear answer (ﬁ gure 3), with GALA dominating the 
analysis by providing 86% of the patients. Also, we could 
not  show any diﬀ erence in quality of life neither at about 
1 month after surgery nor in duration of surgery, time 
spent in intensive therapy or high-dependency units, or 
overall length of hospital stay.
The power of the study was reduced by the lower than 
anticipated perioperative risk of stroke, perhaps because 
surgeons and anaesthetists had chosen to avoid 
randomisation of high-risk patients who they deemed 
unsuitable for one or the other type of anaesthetic, and 
also perhaps because of the improvement of surgical and 
anaesthetic techniques over the years. However, even if 
we had reached our planned sample size of 5000 and the 
absolute risk of primary outcome had been the same, the 
diﬀ erence between general anaesthesia and local 
anaesthesia would still not have been signiﬁ cant.
The absence of blinding might have caused bias in the 
recognition or assessment of outcomes. However, in 
most patients (99%) an independent stroke physician or 
neurologist assessed the primary outcome, and all case 
summaries and their audit were done completely blind 
to treatment allocation.
Some might think that the interventions—randomised 
and not—should have been more strictly standardised; 
however, this would have been impractical in a long-term 
multicentre international study because, if centres had 
been forced into practices they were not familiar with or 
did not approve of, strict standardisation would have 
compromised recruitment.
Lengths of stay in groups under general anaesthesia or 
local anaesthesia did not diﬀ er maybe because 
management protocols were not adjusted to take 
advantage of the potential opportunities that surgery 
under local anaesthesia might have oﬀ ered. Quality-of-life 
data may have been measured too late after surgery to 
capture any early advantage of local anaesthesia.
Anaesthetists and surgeons have suggested that local 
anaesthesia rather than general anaesthesia should 
reduce perioperative morbidity and mortality, particularly 
for patients with severe comorbidities. However, data to 
support this hypothesis are scarce. Most clinical trials in 
various major surgical procedures have failed to show a 
convincing beneﬁ t for local anaesthesia.6,11,12
For carotid surgery, one possible beneﬁ t of local 
anaesthesia could be the increase in systemic blood 
pressure that occurs after carotid clamping under local 
anaesthesia10 and its eﬀ ect in maintaining cerebral 
perfusion. Local anaesthesia could also reduce the stress 
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response to surgery, although other factors (physical 
scale of surgery, size of incision, internal visceral damage, 
and blood loss) aﬀ ect this response more than the type of 
anaesthesia.13 Although patients needing carotid surgery 
typically have severe comorbidity, surgery needs a small 
incision compared with many other vascular operations, 
and is associated with minimal blood loss and ischaemia 
re-perfusion. Thus, the stress response is likely to be 
small and the frequency of complications, such as 
myocardial infarction, chest infection, and venous 
thromboembolism, can also be expected to be small 
compared, for example, with open abdominal aortic 
aneurysm repair, as we showed in the GALA study.
An unknown proportion of perioperative strokes are 
the result of technical issues at the endarterectomy site 
(which at ﬁ rst sight may not seem to be aﬀ ected by the 
type of anaesthesia) rather than of low cerebral-blood ﬂ ow 
during carotid clamping. However, more hurried surgery 
during local anaesthesia or increased use of shunts under 
general anaesthesia might result in arterial trauma, and 
subsequent thrombosis and embolism. Although in the 
GALA study duration of surgery did not diﬀ er between 
the two groups, fewer arteries were patched under local 
anaesthesia, which might have increased the risk of 
neurological complications in this group.14
Local anaesthesia has other possible disadvantages15,16 
that might oﬀ set some of its potential beneﬁ ts during 
carotid surgery. Pain and anxiety during the procedure 
might increase the risk of myocardial ischaemia, 
although patients in this study frequently received 
premedication, and supplementary intra-operative 
sedation and analgesia to keep this to a minimum. A 
patient should be alert enough to do awake neurological 
testing during carotid clamping, but short periods of 
deep sedation might be needed if the patient becomes 
restless or uncomfortable, particularly towards the end 
of the procedure. Such problems are more likely if 
patients are anxious, agitated, or claustrophobic, or have 
comorbidities that make it diﬃ  cult to lie in one position 
for any length of time (such as cardiopulmonary disease 
or joint problems).
Nonetheless, conversion to general anaesthesia may 
still be needed (1·4% of patients in the GALA study), 
which is not without risk, particularly if done in a hurried, 
uncontrolled way. Access to the airway is compromised 
by the surgical drapes, and anaesthetic-induced 
hypotension might cause cerebral hypoperfusion. Also, 
not all patients are psychologically able to tolerate 
procedures while awake.
Occasionally, administration of local anaesthesia for 
carotid surgery results in needle damage to vulnerable 
structures (vertebral artery during deep cervical-plexus 
block, intravascular injection, and phrenic-nerve block) 
and might cause haematoma.15,16 In this study, 
4·4% of patients under local anaesthesia had complications 
that led to cancellation of surgery or conversion to general 
anaesthesia.
In regard to major perioperative complications of 
stroke, myocardial infarction, and death, there is no 
reason to prefer general over local anaesthesia, or vice 
versa, as routine for carotid endarterectomy. Similarly, 
we showed no deﬁ nite evidence that the type of 
anaesthesia aﬀ ects length of hospital stay or quality of 
life. Ideally, therefore, surgical and anaesthetic teams 
should be competent in both techniques because a 
patient might prefer, or there might be a medical reason 
to choose one rather than the other.
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